138 related articles for article (PubMed ID: 6105781)
1. Neuropharmacological and neurochemical approaches to preclinical evaluation of neuroleptics.
Zakusov VV
Adv Biochem Psychopharmacol; 1980; 24():295-303. PubMed ID: 6105781
[No Abstract] [Full Text] [Related]
2. Pharmacology and biochemistry of haloperidol.
Niemegeers CJ; Laduron PM
Proc R Soc Med; 1976; 69 suppl 1(Suppl 1):3-8. PubMed ID: 14331
[No Abstract] [Full Text] [Related]
3. Methodical problems in experimental studies of neuroleptics.
Metys J; Metysová J; Dlabac A; Votava Z
Act Nerv Super (Praha); 1972; 14(2):122-3. PubMed ID: 5040157
[No Abstract] [Full Text] [Related]
4. Neuropharmacological supersensitivity-clinical and experimental correlates and methodological considerations.
Owen RT
Methods Find Exp Clin Pharmacol; 1980 Apr; 2(2):89-95. PubMed ID: 6121962
[TBL] [Abstract][Full Text] [Related]
5. [Attempted neurochemical interpretation of natural behavior and behavior modified by neuroleptics].
Procopiu-Constantinescu T
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1975; 20(2):81-8. PubMed ID: 1081266
[No Abstract] [Full Text] [Related]
6. Pharmacological vs. clinical physiognomy of neuroleptics, with special reference to their sedative and antipsychotic effects.
Nielsen IM
Acta Psychiatr Belg; 1974 Sep; 74(5):473-84. PubMed ID: 4471027
[No Abstract] [Full Text] [Related]
7. Neurophysiological substrates of the pharmacological criteria for neuroleptics.
Stille G
Mod Probl Pharmacopsychiatry; 1970; 5():56-60. PubMed ID: 5527169
[No Abstract] [Full Text] [Related]
8. Pharmacological properties of a new potential neuroleptic drug oxyprothepin. IV. Antiadrenergic action and influence on brain monoamines.
Dlabac A; Metys J; Metysová J
Act Nerv Super (Praha); 1971; 13(3):188-9. PubMed ID: 5113833
[No Abstract] [Full Text] [Related]
9. The basic pharmacology of oxypertine.
Penn RG
Postgrad Med J; 1972 Sep; 48(4):Suppl 4:7-11. PubMed ID: 4202024
[No Abstract] [Full Text] [Related]
10. [Methods of evaluating psychopharmacological agents experimentally].
Barkov NK; Zakusov VV
Farmakol Toksikol; 1973; 36(5):730-9. PubMed ID: 4369618
[No Abstract] [Full Text] [Related]
11. Effect of neuroleptics on brain amphetamine concentrations in the rat.
Lal S; Missala K; Sourkes T
J Pharm Pharmacol; 1971 Dec; 23(12):967-9. PubMed ID: 4402025
[No Abstract] [Full Text] [Related]
12. [Dependence of the antipsychotic effect of neuroleptics on their dopamine-blocking properties].
Arushanian EB
Farmakol Toksikol; 1982; 45(5):118-26. PubMed ID: 6128251
[No Abstract] [Full Text] [Related]
13. A comparison between some biochemical and behavioural effects produced by neuroleptics.
Fregnan GB; Porta R
Arzneimittelforschung; 1981; 31(1):70-4. PubMed ID: 6111328
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular effects of the neuroleptics octoclothepin and oxyprothepin in animals.
Dlabac A; Vanĕcek M
Act Nerv Super (Praha); 1972; 14(2):123-4. PubMed ID: 4625133
[No Abstract] [Full Text] [Related]
15. On the interaction between neuroleptics and antiparkinson drugs.
Julou L
Mod Probl Pharmacopsychiatry; 1970; 5():50-4. PubMed ID: 5527168
[No Abstract] [Full Text] [Related]
16. [L-DOPA jumping test in mice: its use in the study of antagonistic psychotropic drugs].
Gouret C; Raynaud G
C R Seances Soc Biol Fil; 1973; 167(10):1360-6. PubMed ID: 4799982
[No Abstract] [Full Text] [Related]
17. Long-term effects of neuroleptics.
Adv Biochem Psychopharmacol; 1980; 24():1-607. PubMed ID: 6105766
[No Abstract] [Full Text] [Related]
18. Interactions of various drugs with amphetamine.
Garattini S; Jori A; Samanin R
Ann N Y Acad Sci; 1976; 281():409-25. PubMed ID: 798529
[No Abstract] [Full Text] [Related]
19. Preclinical studies with compound GYKI-22441, a new long-acting neuroleptic phenothiazine.
Király I; Borsy J; Tapfer M; Losonczy S; Rásky K; Toldy L; Tóth I
Acta Physiol Hung; 1990; 75 Suppl():171-2. PubMed ID: 1973563
[No Abstract] [Full Text] [Related]
20. Effects of neuroleptics on the cerebral electrical activity of laboratory animals: presentation of a model design for neuropharmacological experiments.
Longo VG; Florio V
Acta Psychiatr Belg; 1970 Nov; 70(6):676-87. PubMed ID: 5517471
[No Abstract] [Full Text] [Related]
[Next] [New Search]